Explore Health Grants Nationwide

The grant aims to support research on how HIV-induced immunometabolic changes in individuals on combination antiretroviral therapy affect immune responses and increase the risk of poor outcomes from secondary infections like Mycobacterium tuberculosis and Hepatitis B Virus. Eligible applicants include small businesses, various government entities, nonprofits, and educational institutions, among others. Application details are not specified in the provided text; for more information, applicants should refer to the full opportunity announcement or contact NIH Grants Information.

The grant aims to support UG3/UH3 phased cooperative agreement research applications for planning and implementing behavioral and social intervention clinical trials related to dental, oral, or craniofacial conditions. Eligible applicants include government entities, nonprofits, small businesses, educational institutions, and various organizations, with specific inclusions for Native American and minority-serving institutions. Applications must be submitted as a single application following the provided instructions, with the UG3 phase focusing on planning and the UH3 phase on conducting intervention research.

The grant aims to support the competing renewal or competitive revision of ongoing clinical trials funded by the National Institute of Dental and Craniofacial Research (NIDCR). Eligible applicants include a wide range of entities such as private and public educational institutions, government agencies, for-profit organizations, and various nonprofit organizations, including those serving Native American populations. Application details are not specified in the provided description; however, interested parties can contact NIH Grants Information for further inquiries.

The grant aims to support UG3/UH3 phased cooperative agreement research applications for planning and implementing clinical trials aligned with the National Institute of Dental and Craniofacial Research (NIDCR) mission. Eligible applicants include various nonprofit organizations, educational institutions, government entities, and for-profit organizations, with specific categories outlined for each. Application details are not provided in the description, but interested parties can contact NIH Grants Information for further inquiries.

The NHLBI Catalyze Program aims to support the transition of basic science discoveries into viable diagnostic and therapeutic candidates for human testing, particularly through the validation of transformative technologies that improve outcomes for HLBS-related diseases. Eligible applicants include government entities, nonprofits, educational institutions, for-profit organizations, and various other organizations, including those serving specific communities. Application details are not specified in the provided text, but interested parties can contact NIH Grants Information for further inquiries.

The NHLBI Catalyze Program aims to support the transition of basic science discoveries into viable diagnostic and therapeutic candidates, facilitating early-stage translational research and product development. Eligible applicants include various nonprofit organizations, educational institutions, government entities, and for-profit organizations, with specific inclusivity for certain minority-serving institutions. Application details are not explicitly provided, but interested parties can contact NIH Grants Information for further inquiries.

The NHLBI Catalyze Program aims to support the transition of basic science discoveries into viable diagnostic and therapeutic candidates for human testing, focusing on early-stage translational support for potential therapeutic candidates targeting HLBS diseases. Eligible applicants include various government entities, small and for-profit businesses, nonprofits, educational institutions, and specific organizations such as HBCUs and tribal colleges. Application details are not provided in the summary, but interested parties can contact NIH Grants Information for further inquiries.

The NHLBI Catalyze Program aims to support the transition of basic science discoveries into viable diagnostic and therapeutic candidates for human testing, specifically through the Catalyze Product Definition initiative focused on identifying potential therapeutic candidates for HLBS diseases. Eligible applicants include various government entities, nonprofits, educational institutions, and for-profit organizations, including small businesses. Application details are not specified in the provided text, but interested parties can contact NIH Grants Information for further inquiries.

The NHLBI Catalyze Program aims to support the transition of basic science discoveries into viable diagnostic and therapeutic candidates for human testing, focusing on early-stage translational support for HLBS diseases. Eligible applicants include government entities, educational institutions, small and for-profit businesses, and various nonprofit organizations, with specific inclusivity for Native American and minority-serving institutions. Application details are not provided in the summary, but interested parties can contact NIH Grants Information for further inquiries.

The purpose of this grant is to support innovative analyses of existing social science, behavioral, administrative, and neuroimaging data to study drug use behaviors, related disorders, and health service utilization. Eligible applicants include private and public institutions of higher education, government entities, nonprofits, and for-profit organizations, among others. Application details are not specified in the provided text; for further information, applicants should refer to the full opportunity announcement or contact NIH Grants Information.

The grant aims to support innovative analyses of existing social science, behavioral, administrative, and neuroimaging data to enhance understanding of drug use behaviors, related disorders, and health service utilization. Eligible applicants include various educational institutions, nonprofits, government entities, and for-profit organizations, including small businesses and tribal organizations. Application details are not specified in the provided text; interested parties should refer to the full opportunity announcement for more information.

The purpose of this grant is to support research aimed at understanding and mitigating the harmful effects of acute exposure to Ultra-Potent Synthetic (UPS) opioids and their combinations, as well as investigating the long-term pathophysiological effects following such exposure. Eligible applicants include various government entities, educational institutions, small and for-profit businesses, and nonprofits, among others. To apply, interested parties should refer to the full opportunity announcement for specific application details and requirements.